Abstract 4849: Targeting the lethal pediatric atypical teratoid/rhabdoid tumors with the DNA minor-groove binding agent quinacrineHarpreet Kaur, Eric H. Raabe, Huizi Guo et al.|Cancer Research|2018Cited by 3
HGG-25. TARGETING THE EPIGENETIC MODIFIER HMGA2 IN DIPG AND HIGH GRADE GLIOMAS INHIBITS PROLIFERATION, INVASION AND TUMORIGENICITYHarpreet Kaur, Eric H. Raabe, Huizi Guo et al.|Neuro-Oncology|2019Cited by 1
Abstract 2888: Targeting the fatal pediatric brain tumors AT/RT and DIPG with the DNA binding agent quinacrineHarpreet Kaur, Eric H. Raabe, Huizi Guo et al.|Tumor Biology|2019Cited by 1
Abstract 4943: The stem cell factor LIN28B regulates proliferation and apoptosis in diffuse intrinsic pontine gliomaHuizi Guo, Eric H. Raabe, Harpreet Kaur et al.|Cancer Research|2020Cited by 1
ATRT-05. REPURPOSED ANTI-MALARIAL QUINACRINE ACTIVATES P53 AND INHIBITS ATRT TUMORIGENICITYHarpreet Kaur, Eric H. Raabe, Peter C Green et al.|Neuro-Oncology|2021Cited by 1